Search research articles
Contact Us
Filters
Showing results (401-410 of 532) with videos related to
Page
of 54
Sort By:
Acta Neuropathologica
|
November 8, 2011
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
Paul A Northcott, David J H Shih, Marc Remke, et al.
Pediatric Blood & Cancer
|
September 22, 2020
Treatment response of CNS high-grade neuroepithelial tumors with MN1 alteration
Lorena V Baroni, Carlos Rugilo, Fabiana Lubieniecki, et al.
Clinical Epigenetics
|
August 15, 2019
DNA methylation signature is prognostic of choroid plexus tumor aggressiveness
Malgorzata Pienkowska, Sanaa Choufani, Andrei L Turinsky, et al.
Neuro-Oncology Advances
|
January 6, 2022
Reevaluating surgery and re-irradiation for locally recurrent pediatric ependymoma-a multi-institutional study
David Y Mak, Normand Laperriere, Vijay Ramaswamy, et al.
Neuro-Oncology Practice
|
August 9, 2020
Bevacizumab for pediatric radiation necrosis
Lorena V Baroni, Daniel Alderete, Palma Solano-Paez, et al.
Pediatric Blood & Cancer
|
May 14, 2020
The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global
Michael Sullivan, Eric Bouffet, Carlos Rodriguez-Galindo, et al.
Clinical Epigenetics
|
October 23, 2019
Correction to: DNA methylation signature is prognostic of choroid plexus tumor aggressiveness
Malgorzata Pienkowska, Sanaa Choufani, Andrei L Turinsky, et al.
JPMA. the Journal of the Pakistan Medical Association
|
September 12, 2024
Consensus guidelines for the management of pediatric medulloblastoma in low and middle-income countries
Naureen Mushtaq, Syed Ather Enam, Mohammad Hamza Bajwa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2018
Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma
Jacques Grill, Maura Massimino, Eric Bouffet, et al.
Neuro-Oncology
|
April 5, 2012
Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis
Michael J Fisher, Michael Loguidice, David H Gutmann, et al.
Page
of 54
Search research articles
Search
Showing results (401-410 of 532) with videos related to
Sort By:
Page
of 54
Acta Neuropathologica
|
November 8, 2011
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
Paul A Northcott, David J H Shih, Marc Remke, et al.
Pediatric Blood & Cancer
|
September 22, 2020
Treatment response of CNS high-grade neuroepithelial tumors with MN1 alteration
Lorena V Baroni, Carlos Rugilo, Fabiana Lubieniecki, et al.
Clinical Epigenetics
|
August 15, 2019
DNA methylation signature is prognostic of choroid plexus tumor aggressiveness
Malgorzata Pienkowska, Sanaa Choufani, Andrei L Turinsky, et al.
Neuro-Oncology Advances
|
January 6, 2022
Reevaluating surgery and re-irradiation for locally recurrent pediatric ependymoma-a multi-institutional study
David Y Mak, Normand Laperriere, Vijay Ramaswamy, et al.
Neuro-Oncology Practice
|
August 9, 2020
Bevacizumab for pediatric radiation necrosis
Lorena V Baroni, Daniel Alderete, Palma Solano-Paez, et al.
Pediatric Blood & Cancer
|
May 14, 2020
The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global
Michael Sullivan, Eric Bouffet, Carlos Rodriguez-Galindo, et al.
Clinical Epigenetics
|
October 23, 2019
Correction to: DNA methylation signature is prognostic of choroid plexus tumor aggressiveness
Malgorzata Pienkowska, Sanaa Choufani, Andrei L Turinsky, et al.
JPMA. the Journal of the Pakistan Medical Association
|
September 12, 2024
Consensus guidelines for the management of pediatric medulloblastoma in low and middle-income countries
Naureen Mushtaq, Syed Ather Enam, Mohammad Hamza Bajwa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2018
Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma
Jacques Grill, Maura Massimino, Eric Bouffet, et al.
Neuro-Oncology
|
April 5, 2012
Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis
Michael J Fisher, Michael Loguidice, David H Gutmann, et al.
Page
of 54